Compare Bumi Resources Minerals Tbk (BRMS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bumi Resources Minerals Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Bumi Resources Minerals Tbk trades at Rp555 (market cap 81.53T, 393.8M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Bumi Resources Minerals Tbk is far larger — about 7.3× Tempo Scan Pacific Tbk.'s market cap, and Bumi Resources Minerals Tbk is more actively traded (393.8M versus 613K). Which is the better fit depends on your goals.
| BRMS | TSPC | |
|---|---|---|
Market Cap | 81.53T | 11.18T |
Volume | 393.8M | 613K |
Lot | 3.94M | 6.13K |
Turnover | 223.64B | 1.54B |
Average Price | 567.9 | 2,511.52 |
Value | 223.64B | 1.54B |
Indicative Equilibrium Price | 555 | 2,520 |
Indicative Equilibrium Volume | 234.77K | 17 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bumi Resources Minerals Tbk
PT Bumi Resources Mineral (the company) was established under its original name of PT Panorama Timur Abadi base on notarial deed No.3 of Mr Safrudin, S.H, dated on 6 Aug, 2003. The Company’s articles of association has been amended several times, most recently by notarial deed No.102 of Humberg Lie, S.H., dated Jun 22, 2010, concerning among others, change the name of the company the composition of the Board of Directors and Commissioners, and public offering.
Read more on BRMS →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
